110 related articles for article (PubMed ID: 15022511)
1. Steroid atrophy.
Hazzard E
Dermatol Nurs; 2004 Feb; 16(1):96. PubMed ID: 15022511
[No Abstract] [Full Text] [Related]
2. What's your assessment? Severe seborrheic dermatitis.
Bielan B
Dermatol Nurs; 2008 Dec; 20(6):454, 472. PubMed ID: 19241741
[No Abstract] [Full Text] [Related]
3. Cutaneous atrophy and alopecia after greater occipital nerve injection using triamcinolone.
Lambru G; Lagrata S; Matharu MS
Headache; 2012; 52(10):1596-9. PubMed ID: 23078270
[TBL] [Abstract][Full Text] [Related]
4. Perilymphatic subcutaneous atrophy in adnexal hemangioma: a complication of intralesional corticosteroid injection.
Ford MD; Codere F
Ophthalmic Surg; 1990 Mar; 21(3):215-7. PubMed ID: 2348971
[TBL] [Abstract][Full Text] [Related]
5. [An iatrogenic complication subsequent to an injection of corticoids into the instep].
Davy A; Guillerot E; Boyer C
Phlebologie; 1986; 39(3):527-37. PubMed ID: 3786426
[TBL] [Abstract][Full Text] [Related]
6. Selective evaluation of a new topical steroid (betamethasone benzoate).
Cullen SI
Curr Ther Res Clin Exp; 1973 May; 15(5):243-7. PubMed ID: 4267808
[No Abstract] [Full Text] [Related]
7. Understanding and treating atopic dermatitis.
Nicol NH; Boguniewicz M
Nurse Pract Forum; 1999 Jun; 10(2):48-55. PubMed ID: 10542581
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies with Halcinonide and fluocortolone in local administration].
Reinhard W; Weber G; Petres J
Z Hautkr; 1974 Apr; 49(7):267-72. PubMed ID: 4275779
[No Abstract] [Full Text] [Related]
9. Letter: Pustular dermatosis on withdrawal of topically applied steroids.
Stegman SJ
Arch Dermatol; 1974 Jan; 109(1):100. PubMed ID: 4271968
[No Abstract] [Full Text] [Related]
10. It's a wrap: the use of wet pajamas in wet-wrap dressings for atopic dermatitis.
Barham KL; Yosipovitch G
Dermatol Nurs; 2005 Oct; 17(5):365-7. PubMed ID: 16294940
[No Abstract] [Full Text] [Related]
11. Non-steroid skin cream in traumatic dermatoses: A clinical open evaluation.
Johnson A
Med J Aust; 1976 Jan; 1(5):111-3. PubMed ID: 131235
[TBL] [Abstract][Full Text] [Related]
12. Facing up to withdrawal from topical steroids.
Smith MC; Nedorost S; Tackett B
Nursing; 2007 Sep; 37(9):60-1. PubMed ID: 17728660
[No Abstract] [Full Text] [Related]
13. Successful strategies in atopic dermatitis management.
Nicol NH; Boguniewicz M
Dermatol Nurs; 2008 Oct; Suppl():3-18; quiz 19. PubMed ID: 19102292
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous linear atrophy following intralesional corticosteroid injection in the treatment of tendonitis.
Cantürk F; Cantürk T; Aydin F; Karagöz F; Sentürk N; Turanli AY
Cutis; 2004 Mar; 73(3):197-8. PubMed ID: 15074349
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for using superpotent topical steroids.
Prawer SE; Katz HI
Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
[TBL] [Abstract][Full Text] [Related]
16. Skin atrophy of the eyelid induced by topical ophthalmic corticosteroids.
Neittaanmäki H; Kontkanen M; Kallioinen M
Acta Ophthalmol Scand; 1998 Jun; 76(3):372-3. PubMed ID: 9686858
[TBL] [Abstract][Full Text] [Related]
17. Ciclopirox shampoo for treating seborrheic dermatitis.
Gupta AK; Bluhm R
Skin Therapy Lett; 2004; 9(6):4-5. PubMed ID: 15334279
[TBL] [Abstract][Full Text] [Related]
18. Atopic dermatitis.
Wade B; Dubinski M
Dermatol Nurs; 2006 Dec; 18(6):586-7. PubMed ID: 17286162
[No Abstract] [Full Text] [Related]
19. [A new corticosteroid for dermatologic use].
Wortmann F
Wien Med Wochenschr; 1972 Nov; 122(47):701-3. PubMed ID: 4264037
[No Abstract] [Full Text] [Related]
20. Overview on desonide 0.05%: a clinical safety profile.
Wong VK; Fuchs B; Lebwohl M
J Drugs Dermatol; 2004; 3(4):393-7. PubMed ID: 15303783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
